Allen Kaplan to Immunoglobulin E
This is a "connection" page, showing publications Allen Kaplan has written about Immunoglobulin E.
Connection Strength
1.617
-
How omalizumab came to be studied as a therapy for chronic spontaneous/idiopathic urticaria. J Allergy Clin Immunol Pract. 2015 Jul-Aug; 3(4):648.
Score: 0.475
-
Treatment of urticaria: a clinical and mechanistic approach. Curr Opin Allergy Clin Immunol. 2019 08; 19(4):387-392.
Score: 0.157
-
Basophil histamine release in patients with chronic spontaneous urticaria: Optimize or minimize. J Allergy Clin Immunol. 2019 08; 144(2):622-623.
Score: 0.156
-
Mechanisms of action that contribute to efficacy of omalizumab in chronic spontaneous urticaria. Allergy. 2017 Apr; 72(4):519-533.
Score: 0.132
-
Responsiveness to human mononuclear cell-derived histamine-releasing factor. Studies of allergic status and the role of IgE. J Immunol. 1988 Oct 15; 141(8):2688-92.
Score: 0.075
-
Treatment of chronic autoimmune urticaria with omalizumab. J Allergy Clin Immunol. 2008 Sep; 122(3):569-73.
Score: 0.074
-
Anti-IgE autoantibodies in systemic lupus erythematosus. Prevalence and biologic activity. Arthritis Rheum. 1988 Aug; 31(8):1000-6.
Score: 0.073
-
Prevalence and functional role of anti-IgE autoantibodies in urticarial syndromes. J Invest Dermatol. 1988 Feb; 90(2):213-7.
Score: 0.071
-
Characterization and functional studies of rheumatoid synovial mast cells. Activation by secretagogues, anti-IgE, and a histamine-releasing lymphokine. Arthritis Rheum. 1986 Aug; 29(8):944-55.
Score: 0.064
-
Pathogenesis and treatment of chronic urticaria. Postgrad Med. 1999 Dec; 106(7 Suppl):12-7.
Score: 0.040
-
Complement dependence of histamine release in chronic urticaria. J Allergy Clin Immunol. 1999 Jul; 104(1):169-72.
Score: 0.039
-
An IgE-dependent histamine-releasing factor (HRF) identical to a previously described human protein (P23) Allergy. 1998 Jul; 53(7):631-2.
Score: 0.037
-
RANTES, a monocyte and T lymphocyte chemotactic cytokine releases histamine from human basophils. J Immunol. 1992 Jul 15; 149(2):636-42.
Score: 0.024
-
Monocyte chemotactic and activating factor is a potent histamine-releasing factor for human basophils. J Exp Med. 1992 Feb 01; 175(2):489-93.
Score: 0.023
-
Urticaria: the relationship of duration of lesion to pathogenesis. Allergy Proc. 1990 Jan-Feb; 11(1):15-8.
Score: 0.020
-
Release of elastase from purified human lung mast cells and basophils. Identification as a Hageman factor cleaving enzyme. Inflammation. 1989 Jun; 13(3):295-308.
Score: 0.019
-
Pathogenesis of chronic urticaria. Clin Exp Allergy. 2009 Jun; 39(6):777-87.
Score: 0.019
-
Recombinant human interleukin-1 beta causes histamine release from human basophils. J Allergy Clin Immunol. 1988 Aug; 82(2):218-23.
Score: 0.018
-
The IgE-dependent release of a Hageman factor cleaving factor from human lung. Am J Pathol. 1986 Apr; 123(1):146-54.
Score: 0.016
-
Increased responsiveness of basophils of patients with chronic urticaria to sera but hypo-responsiveness to other stimuli. Clin Exp Allergy. 2005 Apr; 35(4):456-60.
Score: 0.015
-
Eucalyptus as a specific irritant causing vocal cord dysfunction. Ann Allergy Asthma Immunol. 2004 Sep; 93(3):299-303.
Score: 0.014
-
Idiopathic cold urticaria: in vitro demonstration of histamine release upon challenge of skin biopsies. N Engl J Med. 1981 Oct 29; 305(18):1074-7.
Score: 0.011
-
The pathogenic basis of urticaria and angioedema: recent advances. Am J Med. 1981 Apr; 70(4):755-8.
Score: 0.011
-
The physical urticarias. Int J Dermatol. 1980 Oct; 19(8):417-35.
Score: 0.011
-
Mediators of urticaria and angioedema. J Allergy Clin Immunol. 1977 Nov; 60(5):324-32.
Score: 0.009
-
Mediator release from basophil granulocytes in chronic myelogenous leukemia. J Allergy Clin Immunol. 1976 Dec; 58(6):623-34.
Score: 0.008
-
Neutrophils and mast cells. Comparison of neutrophil-derived histamine-releasing activity with other histamine-releasing factors. J Immunol. 1988 Nov 15; 141(10):3575-83.
Score: 0.005